Program in Health Economics and Outcomes Research Methodology (PHEnOM)

The Program in Health Economics and Outcomes Research Methodology (PHEnOM) at The CHOICE Institute is a joint program with the Department of Health Systems & Population Health in the School of Public Health at the University of Washington, Seattle. The program aims to facilitate intellectual activities within the departments in the fields of health economics, econometrics and methodology development in outcomes research and to engage researchers in allied fields around the city of Seattle. Key competencies of PHEnOM affiliates include health econometrics, health policy evaluation, applications in health capital, aging and disability, organization of health care, simulations methods, and comparative and cost-effectiveness analysis.

The PHEnOM Seminar is also offered as a 1 credit course to interested students. The course, HEOR 598, is a great opportunity for students to receive credit for attending and participating in our weekly research seminars. Please contact us if you have any questions on the details of the course.

Subscribe to the phenom-info email list.

PHEnOM Co-Directors

Douglas Barthold, PhD

Dr. Douglas Barthold joined the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute faculty in 2018, after completing a postdoctoral fellowship at the Schaeffer Center for Health Policy and Economics at the University of Southern California. He received his Ph.D. in Economics from McGill University in 2015, with a specialization in empirical health economics. Dr. Barthold is broadly interested in the relationships between health policies, healthcare utilization, and health outcomes and inequalities. His current research examines the intersection between health policies, chronic disease management, and cognition, from mid-life to end-of-life. This includes the role of health policies in the management of mid-life risk factors for Alzheimer’s disease and related dementias (ADRD), as well as the value of care for conditions that influence healthy aging. Read more: https://sop.washington.edu/people/douglas-barthold

Jing Li, PhD

Dr. Jing Li is an Associate Professor of Health Economics at the CHOICE Institute with research interests in the economic, social and behavioral factors affecting individual decision-making in health and healthcare, for both providers and patients (especially older adults with cognitive impairment), and the impact of policies that leverage these factors to improve patient outcomes and healthcare market efficiency. Methodologically, she is interested in innovatively applying advanced experimental and econometric methods to addressing understudied questions in health economics and policy. Dr. Li was a faculty at Cornell University prior to joining UW. She received a PhD in Health Economics and MA in Economics from University of California, Berkeley, and an MA in International Comparative Education from Stanford University. Read more: https://sop.washington.edu/people/jing-li/

Past Co-Directors: Jerome Dugan, PhD, Norma Coe, PhD, Anirban Basu, PhD

PHEnOM Seminar Series

PHEnOM hosts a weekly seminar series during the academic year. All students, faculty and other researchers interested in this area are welcome to attend the seminar series. The seminar is offered in-person and by Zoom on Wednesday 3 – 4:30pm. In-Person Location: Department of Pharmacy Conference Room, H-371. For the Zoom link, please contact the seminar organizers or subscribe to our list-serv. To present or attend the PHEnOM seminar series, contact Douglas Barthold at barthold@uw.edu or Jing Li at jli0321@uw.edu.

2025 Winter Quarter Seminar Schedule

Dates	Speaker	Title
Apr 2	First Wednesday – no seminar
Apr 9	Davene Wright	The GLP-1 Hunger Games: Developing Innovative Ideas That Will Catch Fire
Apr 16	Kevin Duan	The Impact of the Medicare Competitive Bidding Program on Supplemental Oxygen in COPD
Apr 23	Minttu Ronn	Racial and ethnic disparities in congenital syphilis: analyzing the role of inequalities in prenatal care
Apr 30	Tess Ryckman	Modelling the health & cost benefits of improved regimens to treat TB: which regimen characteristics matter the most?
May 7	Carolyn Rutter	TBD
May 14	ISPOR – no seminar
May 21	Steven Shechter	Optimal matching problems in health care
May 28	Hawre Jalal	Understanding the Exponential Growth of Opioid Overdose Deaths: Patterns, Drivers, and Lessons from the COVID-19 Era
June 4	Last Wednesday – no seminar

Seminar Archives

20252024202320222021202020192018201720162015201420132012

Jan 15
Donghoon Lee
Advancing Mental Health Care for Older Adults: Evidence from Medicare

Jan 22
Virat Agrawal
Understanding the effects of Housing Inflation on Household Alcohol and Tobacco Purchases using a DDD approach

Jan 29
David Kim
Simulation Modeling to Inform Health Policy Decisions: Development, Validation, and Application of the Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model

Feb 5
Lanting Yang
Real-World Insights into Clinical and Pharmaceutical Outcomes of Sodium Glucose Cotransporter 2 Inhibitors

Feb 12
John Giardina
Accurate evaluation of primary prevention policies using joint longitudinal and time-to-event models

Feb 19
Christopher Whaley
Corporate Practice of Medicine: Vertical Alignment and Medicare Advantage Risk Coding

Feb 26
Kyla Woodward
Using US labor data to understand health workforce trends

Mar 5
Yanfang Su
Impact of China’s ‘Zero-markup Policy for Essential Drugs’ on patients, county hospital revenue, and government subsidy levels

Jan 10
Logan Trenaman
Ordering choice sets by complexity in a discrete choice experiment can reduce self-reported attribute non-attendance

Jan 17
Shiven Bhardwaj and Jennifer Bacci
Exploring Association Between Receipt of Pediatric Vaccine at Pharmacy and Timeliness of Well-Child Visits

Jan 24
Lucy Hong and Cheng Chen
Evaluating E-Cigarette Sales Restrictions: Insights into Consumption and Substitution Behavior.

Jan 31
Graeme Peterson
The Geography of Health Disparities

Feb 14
Ziyue Xu
Fracking Boom and Respiratory Health: Evidence from Texas

Feb 21
Maitreyi Sahu
Linking drugs to diagnoses: generating a probabilistic map using Market Scan claims data

Feb 28
Zhang Zhang
The Evaluation of Telehealth Provider Payment Parity on Health Service Utilization among Working-age Population with Chronic Conditions in the US

Apr 3
Jorge Rivero
Type fixed effects and rational addiction: A GMM framework for latent type heterogeneity

Apr 10
Erfan Loghmani
Investigating the Impact of Advertising on Smoking Cessation: The Important Role of DTC Prescription Drug Advertising

Apr 17
Felipe Montano-Campos
Bridging Data Gaps and Predicting Future Trends: A Local Imputation and Prediction Algorithm for Continuous Biomarker Monitoring in Chronic Myeloid Leukemia

Apr 24
Anirban Basu
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies

May 1
Lauren Nicholas
How Do Surrogates Make Treatment Decisions for Patients with Dementia? An Experimental Survey Study

May 15
Esha Dwibedi
Changes in lifetime spending and health-adjusted life-expectancy in the United States, 1996 to 2016

May 22
Riley League
Administrative Burden and Consolidation in Health Care: Evidence from Medicare Contractor Transitions

Oct 2
Pinka Chatterji (presenting author), Chun-Yu Ho, Wenqing Li
Quality effects of nursing home mergers

Oct 9
Harsha Amaravadi
Too Sick to Be True? Evaluating Problematic Coding Practices in Medicare’s Patient Driven Payment Model

Oct 16
Kelly Anderson
Measuring the Effects of Pharmacy Closures

Oct 23
Yongkang Zhang
What Do We Know About Long COVID? Evidence from NIH RECOVER Initiative

Nov 6
Diane Cook
Data Mining a Digital Twin for Cognitive Health Assessment and Intervention

Nov 13
Sijiu Wang
Predictors of Medicaid Enrollment Among Older Adults with Dementia

Nov 20
Omar Galarraga
Evaluating Policies Implemented at the National Level: Double and Triple Difference Applications in Ecuador

Jan 18
Mark Meiselbach
Minimum Wage Laws and the Design and Provision of Employer-Sponsored Health Insurance

Jan 25
Hoa Vu
The Effects of Residential Segregation on Infant Health

Feb 1
Valentyn Litvin
Tried and True or New and Improved? Using Clinical Guidelines to Balance Innovation and Expertise

Feb 8
Vikesh Amin
Does Schooling Improve Cognitive Abilities at Older Ages: Causal Evidence from Nonparametric Bounds

Feb 15
Jens Grueger
Market Access and Implications of IRA beyond the U.S.

Feb 22
Hawre Jalal
Dynamics of Opioid and Drug Overdoses in the United States and Opportunities for Interventions

Mar 29
Yunfei Li
Advancing infectious disease modeling for public health decision-making

Apr 5
Melissa Mugambi
Developing attributes and levels for a discrete choice experiment to design pharmacy-based HIV prevention services for pregnant women in Western Kenya

Apr 12
Alton Russell
Informing targeted public health measures with data-driven decision modeling

Apr 19
Dan Zeltzer
The Impact of Increased Access to Telemedicine

Apr 26
Jakub Hlavka
The Economics of Disease-Modifying Therapies in Alzheimer’s Disease

May 17
Melissa Knox
Using Electronic Health Records for Policy Evaluation: The Case of Seattle’s Sweetened Beverage Tax

May 24
Ramanan Laxminarayan (hosted by the Economics Department – Savery Hall 130)
On the Value of Disease Surveillance

Oct 4
Xiaoxue Li
The Effect of State EITC Expansions on Alcohol Purchase: Evidence from Nielsen Consumer Panel Data

Oct 11
Parker Rogers
Regulating the Innovators: Approval Costs and Innovation in Medical Technologies

Oct 18
Kandice Kapinos
Long-Acting Reversible Contraceptives and Adolescent Childbearing: Changes in Clinical Guidelines for Intrauterine Devices

Nov 1
Monisha Sharma
Maximum price threshold for long-acting PrEP in sub-Saharan Africa: a modeling analysis

Nov 8
Antonio Moreno Llamas
Differences in self-rated health status, mental health symptoms, and physical functioning comparing Spanish and US health surveys in individuals with chronic diseases

Nov 15
Hyunju Kim
Biomarkers of Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction

Nov 29
Stipica Mudrazija
Current and Future Costs of Caregiving for Older Adults with Alzheimer’s Disease and Related Dementias

Jan 5
Brandyn Churchill
Adult Vaccine Recommendations: Morbidity and Firm Response

Jan 12
Kyu Eun Lee
Forecasting the Burden of Disease Using Simulation Models

Jan 19
Ferdous Sardar
Adoption and Impact of Mobile Health Services: Experimental Evidence from Bangladesh

Jan 26
Noah Hammarlund
Isolating the Drivers of Racial Disparities in Emergency Cardiac Surgery

Feb 2
Chuck Phelps
Advances in GRACE methodology

Feb 9
Carol Levin
Economic evaluation of complex interventions. Overview, Application and Results from the Strengthening Economic Evaluation of Multisectoral Strategies for Nutrition (SEEMS-Nutrition)

Feb 16
Karen Smith
Quasi-experimental versus observational methods for modeling the outcomes of blood pressure changes

Feb 23
Sherri Rose
Fairness and Generalizing to Target Populations

Mar 9
Enrique Saldarriaga
Using sociodemographic and political data to identify COVID-19 vaccine hesitancy predictors

Apr 6
Kevin Lu
Trends and effects of health insurance plans with chronic conditions

Apr 13
Vilsa Curto
Price, Steering, and Utilization Effects of Vertical Integration between Physicians and Hospitals

Apr 20
Emily Ann Cuddy
Rules vs. Discretion: Treatment of Mental Illness in US Adolescents

Apr 27
Anirban Basu
Race in Algorithms

May 11
Boshen Jiao
Economic Value of Expanding First-Line Treatment Choices

Jun 1
Susan E. Bronskill
Health system use and outcomes in persons living with dementia: what can we learn from population-based data?

Sep 28
Kayleigh Barnes
The Pink Tax: Gender Differences in Consumption Spending

Oct 5
Min Hee Kim
Mechanistic pathways linking neighborhood disadvantage with cardiovascular risk factors: Quasi-experimental evidence from a refugee dispersal policy in Denmark

Oct 12
Jing Li
Dementia and Long-run Trajectories in Household Finances

Oct 19
Jiani Yu
Physician Management Companies and Prices, Utilization, and Clinical Outcomes: Evidence from Neonatology

Nov 2
Vincent Pohl
Evaluation of the Medicare Care Choices Model

Nov 9
Augustine Denteh
Who Increases Emergency Department Use? New Insights from the Oregon Health Insurance Experiment

Nov 16
Dan Zeltzer T
he Impact of Increased Access to Telemedicine

Nov 30
Donghoon Lee
Do for-profit hospitals cream-skim patients? Evidence from inpatient psychiatric care in California

Dec 7
Manasvini Singh
How Power Shapes Behavior: Evidence from Physicians

Jan 6
Yingying Dong
Regression Discontinuity Designs with a Continuous Treatment

Jan 13
Jill Furzer
Diagnostic errors in child mental health: Assessing treatment selection and its long-term consequences

Jan 20
Kelly Anderson
White and Brown Bagging of Physician-Administered Drugs in Medicare: Uptake and Implications for Spending and Patient Access

Jan 27
Elaine Liu
Malleability in Alcohol Consumption: Evidence from Migrants

Feb 3
Alice Ellyson
Sexual violence reporting among college athletes: A discrete choice experiment

Feb 10
Sindana Ilango
The effect of local-level policies on air pollution and health in aging populations

Feb 17
Noah Hammarlund
Decomposing racial disparities in prostate cancer treatment

Feb 24
Rebecca Myerson
Finding the Missing Enrollees: The Impact of Personalized Assistance on Health Insurance Uptake

Mar 3
Stacie Dusetzina
Drug Prices and Access to Medications in Medicare Part D

Mar 10
Bianca Frogner
Entry and exit patterns of health care workers during COVID

Mar 31
Samin Jalali
Heterogeneities in Medicaid Effect: Evidence from Oregon Health Insurance Experiment

Apr 7
Monica Aswani
Measurement Error in the Hospital Readmission Reduction Program

Apr 14
Maura Coughlin
Regional and Demographic Heterogeneity in Consideration in Medicare Part D Plan Choice

Apr 21
Stacie Dusetzina
Drug prices and access to medications in Medicare Part D

Apr 28
Peter Hull
The mortality effects of Medicare advantage plans

May 5
Pedro H.C. Sant’Anna
Difference-in-Differences with multiple time periods

May 12
Jonathan Roth
When Is Parallel Trends Sensitive to Functional Form?

May 19
Noah Simon
Effect-size estimation in high dimensional problems

May 26
Edward Kennedy
Robust causal inference with continuous instruments using the local instrumental variable curve

Sep 29
Aaron Kesselheim and William Feldman
Estimating Rebates in Studies of Medicare Drug Pricing

Oct 13
Melissa Knox
Employment Quality and Health Behaviors during COVID-19

Oct 20
Chad Meyerhoefer
Do Elections Make You Sick? Evidence from First-Time Voters

Oct 27
Erin Trish
Redesigning Medicare Part D

Nov 3
Nathaniel Hendrix
Radiologist Preferences for Implementation of Artificial Intelligence-Based Clinical Decision Support and Risk Prediction

Nov 10
Job Market Talk

Nov 17
Meng Li
Competition, drug characteristics, and rebate of branded prescription drugs

Dec 8
Neil Jay Sehgal
Gender differences in salary among internal medicine physicians at five academic medical centers in California

Jan 15, 2020
Greg Guzauskas
Cost-effectiveness of Oral Semaglutide for Type 2 Diabetes: An ICER Microsimulation Model

Jan 22, 2020
Betty Bekemeier
A Uniform Chart of Accounts for Public Health: Finally measuring Public Health investments in the United States

Jan 29, 2020
Anirban Basu
Finding Value: Pending Reforms to Prescription Drug Pricing in the United States

Feb 5, 2020
Lauren Strand
Recreational cannabis sales and opioid dispensing: a county-level analysis in Washington State 2014-2018

Feb 12, 2020
Alice Ellyson
The effect of PDMPs on opioid prescribing behavior among the elderly

Feb 19, 2020
Emily Williams
Implementing care for opioid use disorders in VA primary care: an operationally partnered effort

Feb 26, 2020
Wei-Jhih Wang
Mimicking Clinical Trials Using Real-World Data – A Novel Method and Applications

Mar 4, 2020
Charles Phelps
Advances in Cost-Effectiveness-Analysis Methods

Apr 1, 2020
Lauren Olsho
Reducing Early Childhood Obesity: Impacts of Efforts to Improve Nutrition and Physical Activity in Los Angeles County, California

Apr 8, 2020
Kate Johnson
Cost-Effectiveness of Case Detection Strategies for the Early Detection of COPD

Apr 22, 2020
Shuxian Chen
Market dynamics with respect to more generic drug competition

Apr 29, 2020
Tracy Mroz
Variation in Employment of Therapy Assistants in Skilled Nursing Facilities Based on Organizational Factors

May 6, 2020
Jessica Jones-Smith and Kelsey Kinderknecht
Was the Healthy Hunger Free Kids Act of 2010 successful in improving diet quality for lower-income children? Evidence from the National Health and Nutrition Examination Survey

May 13, 2020
Diana Poehler
Developing a Multi-Criteria Decision Analysis ( MCDA) in the Context of Critical Limb Ischemia: Challenges and Solutions

Oct 7, 2020
Erin Morgan
State Earned Income Tax Credits: Anti-Poverty Policy and Health

Oct 14, 2020
Luis Diego Granera
Primary healthcare access and its effects on standard of living: evidence from Costa Rica

Oct 21, 2020
Mark Fendrick
Turning the COVID-19 Crisis into Opportunity: Using Value-Based Insurance Design to Increase Use of High-value Care and Eliminate Low Value Services

Oct 28, 2020
Kosali Simon
Effects of State COVID-19 Closure Policy on NON-COVID-19 Health Care Utilization

Nov 4, 2020
Marcia Weaver
Health spending efficiency in the United States: Cause-Specific Health Spending per Disability-Adjusted Life-Year Averted from 1996 to 2016

Nov 18, 2020
Jinyi Zhu
Evaluating bias and variance across different validation methods of simulation models

Dec 2, 2020
Melissa Knox
Does early childhood access to health insurance affect schooling in Mexico?

Dec 9, 2020
Beth Devine & Enrique Saldarriaga
Assessment of Payers’ Preferences for Real World Evidence: A Discrete Choice Experiment

Jan 9, 2019
Noah Hammarlund
Diagnosing Clinical Treatment Disparities with Machine Learning-Based Decomposition

Jan 16, 2019
Fahad Khalil
Competitive Procurement with Ex Post Moral Hazard

Jan 23, 2019
Marcia Weaver
Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilization of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016

Jan 30, 2019
Kangho Suh
Exploring heterogeneity in effectiveness and safety of newer P2Y12 inhibitors vs. clopidogrel in acute coronary syndrome patients

Feb 6, 2019
Jordan Banks
Final Proposal for the Exploration of HealthCoin: A Currency to Address Potential Underfunding by Commercial Payers for Single or Limited Administration Treatments with Long-Term Efficacy

Feb 13, 2019
Jessica Jones-Smith
Did Seattle’s Excise Tax on Sweetened Beverages Get Passed Through to Customers?

Feb 20, 2019
Bianca Frogner
Accessing Physical Therapy: A National Look at the Diagnosing Provider on Downstream Opioid Use

Feb 27, 2019
Kate Lofgren, Harvard University
VOI for Clinicians and Funders: An Accessible Approach to Value Research Aims

Mar 6, 2019
Kritee Gujral
The impact of hospital closures on surrounding hospitals’ patient outcomes

Mar 13, 2019
Chuck Phelps, Au: Health Economics
THE CHOICE INSTITUTE ANNUAL SYMPOSIUM – “Beyond Cost-Effectiveness – Incorporating and Summarizing Multiple Dimensions of Value in Healthcare Technology Assessment”

Apr 3, 2019
Ankur Pandya
Modeling the Cost Effectiveness of Two Big League Pay-for-Performance Policies

Apr 10, 2019
Noah Hammarlund
Racial Treatment Disparities after Machine Learning Surgery-Appropriateness Adjustment

Apr 17, 2019
Allison Portnoy
Health Gains and Financial Protection from Human Papillomavirus (HPV) Vaccination in Ethiopia

Apr 24, 2019
Anirban Basu
A Health Objective Function for Cost-Effectiveness Analysis Without the Baggage of QALYs

May 1, 2019
Edwin Wong
Estimating Unmet VA Primary Care Using Econometric Disequilibrium Models

May 8, 2019
Alex Woersching
Do Price Shopping Opportunities Justify the Hype Around Price Transparency?

May 15, 2019
Kai Yeung
Impact of Specialty Drug Out-Of-Pocket Cap Laws on Patient Financial Burden

May 29, 2019
Aigbokhai Unuigbe
The Lifecycle of Generics

June 5, 2019
Kate Johnson
Understanding disease trajectory to guide precision policy: a case study in COPD

Sept 25, 2019
Kritee Gujral, PhD
Impact of Rural and Urban Hospital Closures on Inpatient Mortality

Oct 16, 2019
Melissa Knox, PhD
Firm Behavior and the Incidence of Sin Taxes: Evidence from Seattle’s Sweetened Beverage Tax

Nov 6, 2019
Kate Rosettie, MPH
Meta-regression analysis of HPV Vaccine Cost-Effectiveness

Nov 13, 2019
Bianca Frogner, PhD
Where to Start? How the First Point of Care Provider Influences Low Back Pain Outcomes and Cost

Dec 4, 2019
Elizabeth Brouwer
Estimating the drug-specific price elasticity of demand for multiple sclerosis (MS) specialty medications in the Kaiser Permanente Washington system accounting for copay assistance

Dec 11, 2019
Lauren Strand
Recreational and medicinal cannabis sales and opioid dispensing: a county-level analysis in Washington State 2014-2017

January 17, 2018
Jevay Grooms
Race, Gender, and Opioid Treatment Admissions: The Effect of PDMPs on the Most Afflicted

January 24, 2018
Bianca Frogner
Commuting Patterns of Healthcare Workers

January 31, 2018
Carol Levin
Voluntary Male Medical Circumcision (VMMC) costs and unit costs from the Global Health Cost Consortium

February 7, 2018
Gang Luo
Identifying Future High-Cost Patients for Care Management

February 14, 2018
Liisa Laine
Quality and Competition between Public and Private Firms

February 21, 2018
Shan Liu
Optimizing dynamic decision-making: models and insights for chronic disease care

February 28, 2018
Meng Li
The real option value of life and innovation

March 7, 2018
Mark Bounthavong
Providers’ knowledge, attitude, and satisfaction with Academic Detailing in Opioid Overdose Education and Naloxone Distribution

March 28, 2018
Domenico Depalo, Bank of Italy
Explaining the relation between pills and cholesterol through the marginal patient

April 4, 2018
Yates Coley, KPWHRI
Effectively communicating your research results using statistical graphics

April 11, 2018
Liisa Laine
Market-level effects of a Large-Scale School Choice Reform

April 18, 2018
Amber Sabbatini
Hospital observation stays: implications for costs and quality

April 25, 2018
Ragan Hart
Using Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making

May 2, 2018
Peter Neumann
Special Presentation ( jointly sponsored by HICOR, Fred Hutch)

May 9, 2018
Guido Cataife, IMPAQ
Generalization of the Difference-in-Differences Model for Applied Research

May 16, 2018
Alice Ellyson
The Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law